5,0
22. Apr. 2024
Aktueller Mitarbeiter, weniger als 1 Jahr
Austin, TX
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Down to earth, realistic leadership on a valiant mission to disrupt the pharma space. Team is close and vibes well together.
Kontras
Revenue will sometimes supersede mission, but company checks and balances usually brings them back on track.